Hearing loss after cisplatin-based chemotherapy: Patient-reported outcomes versus audiometric assessments.

5016Background: Although pure-tone audiometry is the gold standard to evaluate hearing loss (HL), patient-reported outcomes are practically more time and cost effective. However, no data exist on f...